文献速递胃肠动力与功能性疾病

心理韧性在肠易激综合征、其他慢性胃肠道疾病及一般人群中的作用

The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-08-21

该在线调查研究比较了肠易激综合征(IBS)患者、其他慢性胃肠道疾病患者与一般人群的心理韧性,发现IBS患者韧性低于一般人群,但与症状相似的其他慢性胃肠道疾病患者相当;低韧性关联更重的IBS症状和更差的心理健康,可能成为新的治疗靶点。

要点

  • IBS患者心理韧性低于一般人群,但与症状相似的其他慢性胃肠道疾病患者相当。
  • 低心理韧性关联更重的IBS症状严重度和更差的心理健康。
  • 早期不良生活事件与IBS患者和一般人群从逆境中恢复的能力下降相关。

核心结论

  • 心理韧性低于美国一般人群,但似乎并非IBS特有,因为其与其他慢性胃肠道疾病相当。
  • 低心理韧性对症状严重度和心理健康产生负面影响,因此可能作为新的治疗靶点。

研究设计与样本

  • 一般人群参与者完成在线调查,问卷测量人口学、IBS及其他胃肠道疾病诊断、症状严重度、心理症状、心理韧性和早期不良生活事件。
  • IBS定义为有医生诊断的IBS和/或符合罗马标准且无共病胃肠道疾病,其余纳入一般人群组。
  • 慢性胃肠道疾病组包括炎症性肠病、乳糜泻和/或显微镜下结肠炎患者。

主要发现

  • IBS组心理韧性低于一般人群组(IBS n=820 vs 一般人群 n=1026,p<0.001)。
  • 心理韧性与更重的IBS症状严重度相关(p<0.05)。
  • 整体心理健康对心理韧性的影响在IBS组与一般人群组间不同(所有p<0.05)。
  • 早期不良生活事件与IBS组和一般人群组从逆境中恢复的能力下降相关(p<0.001)。
  • 心理韧性评分在IBS与症状相似的其他慢性胃肠道疾病间相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Resilience is the ability to adapt positively to stress and adversity. It is a potential therapeutic target as it is reduced in irritable bowel syndrome (IBS) compared to healthy controls and associated with worse symptom severity and poorer quality of life. The aim of this study was to examine if these findings are generalizable by comparing resilience between IBS versus the general population and other chronic gastrointestinal (GI) conditions. METHODS: Participants in the general population completed an online survey containing questionnaires measuring demographics, diagnosis of IBS and other GI conditions, symptom severity, psychological symptoms, resilience, and early adverse life events (EALs). IBS was defined as having a physician diagnosis of IBS and/or meeting Rome criteria without co-morbid GI disease. All others were included in the general population group. The chronic GI conditions group included those with inflammatory bowel disease, celiac disease and/or microscopic colitis. RESULTS: Resilience was lower in IBS (n = 820) than the general population (n = 1026; p < 0.001) and associated with worse IBS symptom severity (p < 0.05). Global mental health affected resilience differently in IBS compared to the general population (all p's < 0.05). EALs were associated with decreased ability to bounce back from adversity in both IBS and the general population (p < 0.001). Resilience scores were similar in IBS and other chronic GI conditions that present with similar symptoms. CONCLUSIONS: Resilience is lower compared to the general U.S. population but does not appear to be specific to IBS as it is comparable to other chronic GI conditions. Low resilience negatively affects symptom severity and mental health and thus, may serve as a novel therapeutic target.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Parker CH, Naliboff BD, Shih W, et al. The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population. Clin Gastroenterol Hepatol. 2020. PMID: 32835842. doi:10.1016/j.cgh.2020.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。